Cargando…
PHF6 and JAK3 mutations cooperate to drive T-cell acute lymphoblastic leukemia progression
T-cell acute lymphoblastic leukemia (T-ALL) is a malignant hematologic disease caused by gene mutations in T-cell progenitors. As an important epigenetic regulator, PHF6 mutations frequently coexist with JAK3 mutations in T-ALL patients. However, the role(s) of PHF6 mutations in JAK3-driven leukemia...
Autores principales: | Yuan, Shengnan, Wang, Xiaomin, Hou, Shuaibing, Guo, Tengxiao, Lan, Yanjie, Yang, Shuang, Zhao, Fei, Gao, Juan, Wang, Yuxia, Chu, Yajing, Shi, Jun, Cheng, Tao, Yuan, Weiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807395/ https://www.ncbi.nlm.nih.gov/pubmed/34465864 http://dx.doi.org/10.1038/s41375-021-01392-1 |
Ejemplares similares
-
PHF6 maintains acute myeloid leukemia via regulating NF-κB signaling pathway
por: Hou, Shuaibing, et al.
Publicado: (2023) -
R274X-mutated Phf6 increased the self-renewal and skewed T cell differentiation of hematopoietic stem cells
por: Lan, Yanjie, et al.
Publicado: (2023) -
Rapamycin Promotes the Expansion of Myeloid Cells by Increasing G-CSF Expression in Mesenchymal Stem Cells
por: Li, Minghao, et al.
Publicado: (2022) -
PHF6 mutations in T-cell acute lymphoblastic leukemia
por: Van Vlierberghe, Pieter, et al.
Publicado: (2010) -
High Expression of Microtubule-associated Protein TBCB Predicts Adverse Outcome and Immunosuppression in Acute Myeloid Leukemia
por: Wang, Bichen, et al.
Publicado: (2023)